Publikacje


Nicotine produces antidepressant-like actions: Behavioral and neurochemical evidence. Piotr Popik, Martyna Krawczyk, Tomasz Kos, Irena Nalepa, Marta Kowalska, Tadeusz Witarski, Lucyna Antkiewicz-Michaluk, Jerzy Vetulani
European journal of pharmacology,
PMID:15893747

Piątek, 27 Maja 2005
A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice. T Kos, P Popik
Behavioural pharmacology,
PMID:15864070

Poniedziałek, 2 Maja 2005
Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance. Wojciech Danysz, Ewa Kozela, Chris G Parsons, Meik Sladek, Tanja Bauer, Piotr Popik
Neuropharmacology,
PMID:15721168

Poniedziałek, 21 Lutego 2005
"Broad spectrum" antidepressants: is more better for the treatment of depression? Phil Skolnick, Piotr Popik, Aaron Janowsky, Bernard Beer, Arnold S Lippa
Life sciences,
PMID:14561522

Czwartek, 16 Października 2003
Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram. Piotr Popik, Ewa Kozela, Martyna Krawczyk
British journal of pharmacology,
PMID:12871839

Poniedziałek, 21 Lipca 2003
Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice. P Popik, M Wrobel, R Rygula, A Bisaga, A Y Bespalov
Behavioural pharmacology,
PMID:12799526

Środa, 11 Czerwca 2003
Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA. Piotr Popik, Ewa Kozela, Malgorzata Wróbel, Krystyna M Wozniak, Barbara S Slusher
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
PMID:12629525

Wtorek, 11 Marca 2003
Antidepressant-like actions of DOV 21,947: a  Phil Skolnick, Piotr Popik, Aaron Janowsky, Bernard Beer, Arnold S Lippa
European journal of pharmacology,
PMID:12586204

Piątek, 14 Lutego 2003
Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. P Popik, M Wróbel
Neuropharmacology,
PMID:12527470

Środa, 15 Stycznia 2003